Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | 7-hydroxystaurosporine |
Trade Name | |
Synonyms | UCN-01|KRX-0601|NSC-638850 |
Drug Descriptions |
7-hydroxystaurosporine (UCN-01) is a derivative of staurosporine that inhibits CHK1 and PKC, with higher potency toward PKC-alpha, PKC-beta, and PKC-gamma, and also modulates CDK activity through upregulation of CDK inhibitors, potentially resulting in inhibition of tumor growth (PMID: 8022414, PMID: 15831461, PMID: 15150122, PMID: 31942030). |
DrugClasses | CDK Inhibitor (Pan) 3 CHK1 Inhibitor 18 PKC alpha Inhibitor 6 PKC beta Inhibitor 6 PKC Inhibitor (Pan) 11 |
CAS Registry Number | 112953-11-4 |
NCIT ID | C1271 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
7-hydroxystaurosporine | 7-hydroxystaurosporine | 0 | 0 |
7-hydroxystaurosporine + Sirolimus | 7-hydroxystaurosporine Sirolimus | 0 | 0 |